Abstract
We have previously demonstrated that collagen type XV (ColXV) is a novel bone extracellular matrix (ECM) protein. It is well known that the complex mixture of multiple components present in ECM can help both to maintain stemness or to promote differentiation of stromal cells following change in qualitative characteristics or concentrations. We investigated the possible correlation between ColXV expression and mineral matrix deposition by human mesenchymal stromal cells (hMSCs) with different osteogenic potential and by osteoblasts (hOBs) that are able to grow in culture medium with or without calcium. Analysing the osteogenic process, we have shown that ColXV basal levels are lower in cells less prone to osteo‐induction such as hMSCs from Wharton Jelly (hWJMSCs), compared to hMSCs that are prone to osteo‐induction such as those from the bone marrow (hBMMSCs). In the group of samples identified as ‘mineralized MSCs’, during successful osteogenic induction, ColXV protein continued to be detected at substantial levels until early stage of differentiation, but it significantly decreased and then disappeared at the end of culture when the matrix formed was completely calcified. The possibility to grow hOBs in culture medium without calcium corroborated the results obtained with hMSCs demonstrating that calcium deposits organized in a calcified matrix, and not calcium ‘per se’, negatively affected ColXV expression. As a whole, our data suggest that ColXV may participate in ECM organization in the early‐phases of the osteogenic process and that this is a prerequisite to promote the subsequent deposition of mineral matrix.
Highlights
Mesenchymal stromal cells (MSCs) can differentiate into cells of mesodermal lineages such as cartilage, bone and adipose tissue [1]
We have investigated the impact of the presence of collagen type XV (ColXV) on mineral matrix deposition by human mesenchymal stromal cells (hMSCs) with different osteogenic potential and on human osteoblasts cells
Cell culture hMSCs were isolated from two sources, human bone marrow and Wharton’s jelly of umbilical cords. hBMMSCs were obtained, as previously reported [30], from bone marrow aspirates harvested by the iliac crest, after obtaining the patients’ informed consent and the approval of the Istituto Ortopedico Rizzoli Ethics Committee. hWJMSCs were isolated from human umbilical cords collected after the mothers’ informed consent and the approval of the University of Ferrara and S
Summary
Mesenchymal stromal cells (MSCs) can differentiate into cells of mesodermal lineages such as cartilage, bone and adipose tissue [1]. By gene array profile and immunohistological analysis, we have previously identified ColXV as a novel human osteoblast (OB) matrix protein [29], and our interest is to investigate a possible involvement of this type of collagen in triggering bone intracellular signalling pathways and regulating osteogenic cell growth and differentiation.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
